Semi-quantitative scoring of skeletal metastases by 123I-mIBG scintigraphy in high-risk neuroblastoma Mark N. Gaze Editorial 03 March 2017 Pages: 1251 - 1253
Advanced Hodgkin’s lymphoma: End-of-treatment FDG-PET should be maintained Elif HindiéCharles MesguichNoël Milpied Editorial 02 May 2017 Pages: 1254 - 1257
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients Ali Afshar-OromiehTim Holland-LetzUwe Haberkorn Original Article Open access 12 May 2017 Pages: 1258 - 1268
Comparison of CT and PET/CT for biopsy guidance in oncological patients Juliano J. CerciElena TabacchiJoão Vicente Vitola Original Article 31 March 2017 Pages: 1269 - 1274
Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer Joshua H. FinkleStephanie Y. JoYonglin Pu Original Article 07 March 2017 Pages: 1275 - 1284
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study Cornelius DeuschlChristoph MoenninghoffMarc Schlamann Original Article 03 March 2017 Pages: 1285 - 1295
Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer Dawei JiangHyung-Jun ImWeibo Cai Original Article 06 March 2017 Pages: 1296 - 1305
IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas A. VergerPh. MetellusE. Guedj Original Article 14 March 2017 Pages: 1306 - 1311
Impact of 18F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis Andrea ForschnerSusann-Cathrin OlthofChristina Pfannenberg Original Article 18 March 2017 Pages: 1312 - 1318
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial Joyce M. van Dodewaard-de JongJohn M. H. de KlerkAlfons J. M. van den Eertwegh Original Article 18 April 2017 Pages: 1319 - 1327
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics Martin PoolAnton G. T. Terwisscha van ScheltingaMarjolijn N. Lub-de Hooge Original Article Open access 19 March 2017 Pages: 1328 - 1336
Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT Dan SandbergVladimir TolmachevJens Sörensen Original Article Open access 06 March 2017 Pages: 1337 - 1346
Preclinical imaging characteristics and quantification of Platinum-195m SPECT E. A. AalbersbergB. J. de Wit – van der VeenWouter V. Vogel Original Article 11 February 2017 Pages: 1347 - 1354
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline Nare TorosyanKelsey Masonthe Alzheimer’sDisease Neuroimaging Initiative Original Article 22 March 2017 Pages: 1355 - 1363
Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden Janusch BlautzikMatthias Brendelfor the Alzheimer’s Disease Neuroimaging Initiative Original Article 22 March 2017 Pages: 1364 - 1374
The relationship between the dopaminergic system and depressive symptoms in cervical dystonia E. ZoonsM. A. J. TijssenJ. Booij Original Article Open access 17 March 2017 Pages: 1375 - 1382
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis Lien BekaertSamuel ValableJean-Sébastien Guillamo Original Article 18 March 2017 Pages: 1383 - 1392
Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis – a systematic review of the recent literature Geertje A. GovaertFrank F. IJpmaAndor W. Glaudemans Review Article Open access 27 April 2017 Pages: 1393 - 1407
Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas? A. VergerD. TaiebE. Guedj Letter to the Editor 27 April 2017 Pages: 1408 - 1410
“The simplest explanation is usually the correct one” – Can Occam’s razor be applied for diffuse astrocytoma and paradoxical amino acid metabolism? Egesta Lopci Reply 03 May 2017 Pages: 1411 - 1412
Hypercalcemia revealing diffuse granulomatous myositis Weniko CaréEstelle BlancStéphane Lecoules Image of the Month 10 April 2017 Pages: 1413 - 1414
Valentina Ambrosini and Stefano Fanti (eds): Clinicians’ Guides to Radionuclide Hybrid Imaging: PET/CT in Neuroendocrine Tumors Manuela AmatoLuigi Mansi Book Review 26 January 2017 Pages: 1415 - 1415